Mycosis Fungoides — Trials

Mycosis Fungoides — Trials · CancerIndex

Clinical trials

Registered studies

126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 30
Recruiting: 15
Ph III recruiting: 0
Growth YoY: —
Industry share: 13%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 47.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (30)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05538988	BIOmarker-guided Study to Evaluate the Efficacy and Safety of cemipLimab for advancEd Cutaneous T-cell Lymphoma(BIOSELECT)	withdrawn	Phase 1 / Phase 2	0	AHS Cancer Control AlbertaOTHER	1	Jun 27, 2025	clinicaltrials
NCT03373305	Brentuximab Vedotin and Lenalidomide in Treating Patients With Relapsed or Refractory T-Cell Lymphomas	withdrawn	Phase 1	0	City of Hope Medical CenterOTHER	1	Apr 30, 2019